Refine by
Respiratory Virus Services
4 services found
Manufactured by:Atriva Therapeutics GmbH based inTübingen, GERMANY
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two disease areas with urgent need for effective ...
by:Moichor Inc. based inSan Fransisco, CALIFORNIA (USA)
What solutions are available for what species: Avian & Reptile; Exotic Mammals; Small Mammals; ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Custom In Vivo Models and Testing Solutions. Selecting the appropriate in vivo model for your assays is critical for the success of your preclinical research program. At Nexelis, a Q² Solutions Company, we designed and developed disease specific in vivo models alongside bespoke personalized model development services. Our wealth of experience and capabilities allows us to help answer our ...
by:GENETWORx, LLC. based inGlen Allen, VIRGINIA (USA)
COVID-19, influenza, and respiratory syncytial virus (RSV) are respiratory illnesses caused by different viruses. Because they have similar symptoms it can be difficult to tell them ...